Counterpulsation Reduces Infarct Size Pre-PCI for AMI (CRISP-AMI)
A Multi-center, Randomized, Controlled Study of Mechanical Left Ventricular Unloading With Counterpulsation to Reduce Infarct Size Pre-PCI for Acute Myocardial Infarction - CRISP AMI
Sponsor: Datascope Corp.
Listed as NCT00833612, this PHASE4 trial focuses on Acute Myocardial Infarction (AMI) and remains completed. Sponsored by Datascope Corp., it has been updated 6 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Dec 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Datascope Corp.
- Duke University
- Flinders Medical Centre
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bangalore, India , Bedford Park, Australia , Birmingham, United States , Boston, United States , Delhi, India , Dorset, United Kingdom , Dresden, Germany , Dublin, Ireland , Duluth, United States , Durham, United States and 24 more locations